Results 191 to 200 of about 153,362 (337)

Diseases of the Ear, Nose, and Throat [PDF]

open access: yesAnnual Review of Medicine, 1950
Walter E. Loch   +2 more
openaire   +3 more sources

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella   +12 more
wiley   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon   +6 more
wiley   +1 more source

Ear, nose and throat disorders and international travel. [PDF]

open access: yesTrop Dis Travel Med Vaccines
McHugh N   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy